13-20189451-C-T
Variant summary
The NM_004004.6(GJB2):c.131G>A (p.Trp44*) variant causes a stop gained change involving the alteration of a conserved nucleotide. This is a loss-of-function variant that does not trigger NMD. The variant allele was found at a cumulative frequency of 0.0000062 (AC=10) in the gnomAD database across 1,613,034 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000886. In-silico predictor (BayesDel (noAF)) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 7.85). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★).
Frequency
Consequence
NM_004004.6 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Bart-Pumphrey syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
- hearing loss disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- ichthyosis, hystrix-like, with hearing lossInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P
- keratoderma hereditarium mutilansInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
- palmoplantar keratoderma-deafness syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
- autosomal recessive nonsyndromic hearing loss 1AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- autosomal dominant keratitis-ichthyosis-hearing loss syndromeInheritance: AD Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics, PanelApp Australia
- autosomal dominant nonsyndromic hearing loss 3AInheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- KID syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 13 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PVS1Null variant in LOF gene | Non-NMD frameshift: ≥4 downstream pathogenic — very strong evidence preserved (PVS1); Stop-gained (exon 2 of 2) at amino acid 44 of 226; NMD not predicted. 213 pathogenic variants downstream support preserved loss-of-function impact. | ||
| PM2Absent/extremely low in population databases | Rare in gnomAD for AD/XL gene (popmax AF below threshold) — PM2 Supporting; GnomAD popmax AF = 0.0000886 — borderline rare for AD+AR gene (base 0.0001, raised to 0.0005 by highest known P/LP ClinVar AF 0.012) — PM2 supporting. | ||
| PP5Reputable source reports pathogenic | ClinVar 2-star pathogenic — strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). ClinVar submissions strongly and reliably favor pathogenicity (17/17 total P/LP). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_004004.6. You can select a different transcript below to see updated classification assignments.
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
GJB2 | TSL:1MANE Select | c.131G>A p.Trp44* | stop_gained | Exon 2 of 2 | Prot: ENSP00000372299.4 UniProt: | |
GJB2 | TSL:6 | c.131G>A p.Trp44* | stop_gained | Exon 1 of 1 | Prot: ENSP00000372295.1 UniProt: | |
GJB2 | c.131G>A p.Trp44* | stop_gained | Exon 2 of 2 | Prot: ENSP00000576289.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.0000131 | AC:2 | Hom:0 | AN:152178 | Cov:33 |
GnomAD2 exomes | AF: 0.0000239 | AC:6 | AN:250896 | ||
GnomAD4 exome | AF: 0.00000548 | AC:8 | Hom:0 | AN:1460856 | Cov:33 |
GnomAD4 genome | AF: 0.0000131 | AC:2 | Hom:0 | AN:152178 | Cov:33 |
TOPMed (Bravo) | AF: 0.0000151 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.00 | AC:0 | Hom:0 | AN:13470 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
SCHEMA | 0.0000194 | 2 | 103184 | 0.00000543 | 1 | 184256 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 39 | |
BayesDel_addAF | Pathogenic | 0.36 | D |
BayesDel_noAF | Pathogenic | 0.54 | |
CADD | Pathogenic | 42 | |
DANN | Uncertain | 1.0 | |
Eigen | Pathogenic | 0.96 | |
Eigen_PC | Pathogenic | 0.83 | |
FATHMM_MKL | Uncertain | 0.97 | D |
GPN-Star LLR | N/A | -8.6 | |
GPN-Star score | N/A | 8.6 | |
Mutation Taster | N/A | 1/199 | disease causing (ClinVar) |
PhyloP100 | Pathogenic | 7.9 | |
PromoterAI | N/A | -0.026 | Neutral |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.